Literature DB >> 11566485

Cancer chemopreventive agents, serratane-type triterpenoids from Picea jezoensis.

R Tanaka1, T Minami, K Tsujimoto, S Matsunaga, H Tokuda, H Nishino, Y Terada, A Yoshitake.   

Abstract

Seven serratane-type triterpenoids isolated from the cuticle of Picea jezoensis (Sieb. et Zucc.) Carr. jezoensis (Pinaceae) and the stem bark of Picea jezoensis (Sieb. et Zucc.) Carr. hondoensis (Mayer) Rehder (Pinaceae) were studied their possible inhibitory effects on Epstein-Barr virus early antigen (EBV-EA) activation induced by 12-O-tetradecanoylphorbol-13-acetate (TPA). All compounds showed strong inhibitory effects on the EBV-EA activation, being stronger than that of oleanolic acid, which exerts on cancer preventive activity in animal carcinogenesis models. Among these compounds, 13alpha, 14alpha-epoxy-3beta-methoxyserratan-21beta-ol and 3beta-methoxy-21alpha-hydroxyserrat-14-en-29-al were investigated for the inhibitory effects in a two-stage mouse skin carcinogenesis test on mouse skin using 7,12-dimethylbenz[a]anthracene as initiator and TPA as promoter. 13alpha,14alpha-Epoxy-3beta-methoxyserratan-21beta-ol was found to exhibit the excellent anti-tumor promoting activity in the in vivo carcinogenesis test.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11566485     DOI: 10.1016/s0304-3835(01)00650-4

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  2 in total

1.  Oleanolic acid derivatives induce apoptosis in human leukemia K562 cell involved in inhibition of both Akt1 translocation and pAkt1 expression.

Authors:  Shuhua Pan; Jun Hu; Tingting Zheng; Xinyuan Liu; Yong Ju; Chuanlian Xu
Journal:  Cytotechnology       Date:  2014-04-12       Impact factor: 2.058

2.  Synthesis of thiocarbohydrazide and carbohydrazide derivatives as possible biologically active agents.

Authors:  Kiran Gangarapu; Sarangapani Manda; Anvesh Jallapally; Sreekanth Thota; Subhas S Karki; Jan Balzarini; Erik De Clercq; Harukuni Tokuda
Journal:  Med Chem Res       Date:  2013-08-23       Impact factor: 1.965

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.